Parya Saberi, PharmD

  • Assistant Professor, UCSF School of Medicine

Biography

Parya Saberi, PharmD, MAS is an Assistant Professor at the Center for AIDS Prevention Studies in the Department of Medicine at the University of California, San Francisco. She is also an HIV Clinical Pharmacist at Ward 86 (Positive Health Program) at San Francisco General Hospital. Dr. Saberi's is funded by the National Institute of Mental Health through a K23 Mentored Patient-oriented Research Career Development Award. Her current area of research includes adapting technology-based strategies to improve antiretroviral adherence and engagement in HIV Care among HIV-positive youth. These methods include social networking technologies, video-conferencing tools, and text messaging. Additionally, she is involved in the development of an index of engagement in HIV care as well as research regarding retention and adherence to HIV care in South Africa.

Displaying 1 - 32 of 32

  1. van den Berg JJ, Neilands TB, Johnson MO, Chen B, Saberi P. Using Path Analysis to Evaluate the Healthcare Empowerment Model Among Persons Living with HIV for Antiretroviral Therapy Adherence. AIDS Patient Care STDS. 2016 Nov; 30(11):497-505. View on Pubmed
  2. Saberi P, Siedle-Khan R, Sheon N, Lightfoot M. The Use of Mobile Health Applications Among Youth and Young Adults Living with HIV: Focus Group Findings. AIDS Patient Care STDS. 2016 Jun; 30(6):254-60. View on Pubmed
  3. Lippman SA, Shade SB, Sumitani J, DeKadt J, Gilvydis JM, Ratlhagana MJ, Grignon J, Tumbo J, Gilmore H, Agnew E, Saberi P, Barnhart S, Steward WT. Evaluation of short message service and peer navigation to improve engagement in HIV care in South Africa: study protocol for a three-arm cluster randomized controlled trial. Trials. 2016; 17(1):68. View on Pubmed
  4. Sauceda JA, Johnson MO, Saberi P. Nonadherence as 4-day Antiretroviral Therapy Interruptions: Do Depression and Race/Ethnicity Matter as Much in the Modern Antiretroviral Therapy Era? AIDS Behav. 2016 Jan 14. View on Pubmed
  5. Gilvydis JM, Steward WT, Saberi P, Tumbo J, Sumitani J, Barnhart S, Lippman SA. Need for improvements in clinical practice to retain patients in pre-antiretroviral therapy care: Data from rural clinics in North West Province, South Africa. AIDS Care. 2015 Oct; 27(10):1275-8. View on Pubmed
  6. Saberi P, Johnson MO. Correlation of Internet Use for Health Care Engagement Purposes and HIV Clinical Outcomes Among HIV-Positive Individuals Using Online Social Media. J Health Commun. 2015; 20(9):1026-32. View on Pubmed
  7. Saberi P, Catz SL, Leyden WA, Stewart C, Ralston JD, Horberg MA, Grothaus L, Silverberg MJ. Antiretroviral Therapy Adherence and Use of an Electronic Shared Medical Record Among People Living with HIV. AIDS Behav. 2015 Jun; 19 Suppl 2:177-85. View on Pubmed
  8. Saberi P, Neilands TB, Vittinghoff E, Johnson MO, Chesney M, Cohn SE. Barriers to antiretroviral therapy adherence and plasma HIV RNA suppression among AIDS clinical trials group study participants. AIDS Patient Care STDS. 2015 Mar; 29(3):111-6. View on Pubmed
  9. Saberi P, Mayer K, Vittinghoff E, Naar-King S. Correlation between use of antiretroviral adherence devices by HIV-infected youth and plasma HIV RNA and self-reported adherence. AIDS Behav. 2015 Jan; 19(1):93-103. View on Pubmed
  10. Saberi P, Johnson MO. Moving toward a novel and comprehensive behavioral composite of engagement in HIV care. AIDS Care. 2015; 27(5):660-4. View on Pubmed
  11. Saberi P, Neilands TB, Johnson MO. Association between dog guardianship and HIV clinical outcomes. J Int Assoc Provid AIDS Care. 2014 Jul-Aug; 13(4):300-4. View on Pubmed
  12. Yuan P, Bare MG, Johnson MO, Saberi P. Using online social media for recruitment of human immunodeficiency virus-positive participants: a cross-sectional survey. J Med Internet Res. 2014; 16(5):e117. View on Pubmed
  13. Sevelius JM, Saberi P, Johnson MO. Correlates of antiretroviral adherence and viral load among transgender women living with HIV. AIDS Care. 2014; 26(8):976-82. View on Pubmed
  14. Cocohoba J, Dong BJ, Johnson MO, Saberi P. Reporting of critical information in studies of pharmacists in HIV care. Int J Pharm Pract. 2014 Dec; 22(6):375-85. View on Pubmed
  15. Saberi P, Yuan P, John M, Sheon N, Johnson MO. A pilot study to engage and counsel HIV-positive African American youth via telehealth technology. AIDS Patient Care STDS. 2013 Sep; 27(9):529-32. View on Pubmed
  16. Saberi P, Comfort M, Sheon N, Johnson MO. Qualitative study of the quality of sleep in marginalized individuals living with HIV. Patient Prefer Adherence. 2013; 7:499-507. View on Pubmed
  17. Saberi P, Phengrasamy T, Nguyen DP. Inhaled corticosteroid use in HIV-positive individuals taking protease inhibitors: a review of pharmacokinetics, case reports and clinical management. HIV Med. 2013 Oct; 14(9):519-29. View on Pubmed
  18. Saberi P, Gamarel KE, Neilands TB, Comfort M, Sheon N, Darbes LA, Johnson MO. Ambiguity, ambivalence, and apprehensions of taking HIV-1 pre-exposure prophylaxis among male couples in San Francisco: a mixed methods study. PLoS One. 2012; 7(11):e50061. View on Pubmed
  19. Bruno C, Saberi P. Pharmacists as providers of HIV pre-exposure prophylaxis. Int J Clin Pharm. 2012 Dec; 34(6):803-6. View on Pubmed
  20. Saberi P, Caswell NH, Jamison R, Estes M, Tulsky JP. Directly observed versus self-administered antiretroviral therapies: preference of HIV-positive jailed inmates in San Francisco. J Urban Health. 2012 Oct; 89(5):794-801. View on Pubmed
  21. Saberi P, Comfort M, Johnson MO. The relationship between daily organization and adherence to antiretroviral therapy: a qualitative perspective. J Acquir Immune Defic Syndr. 2012 Sep 1; 61(1):e3-6. View on Pubmed
  22. Johnson MO, Sevelius JM, Dilworth SE, Saberi P, Neilands TB. Preliminary support for the construct of health care empowerment in the context of treatment for human immunodeficiency virus. Patient Prefer Adherence. 2012; 6:395-404. View on Pubmed
  23. Saberi P, Dong BJ, Johnson MO, Greenblatt RM, Cocohoba JM. The impact of HIV clinical pharmacists on HIV treatment outcomes: a systematic review. Patient Prefer Adherence. 2012; 6:297-322. View on Pubmed
  24. Saberi P, Johnson MO. Technology-based self-care methods of improving antiretroviral adherence: a systematic review. PLoS One. 2011; 6(11):e27533. View on Pubmed
  25. Saberi P, Johnson MO, McCulloch CE, Vittinghoff E, Neilands TB. Medication adherence: tailoring the analysis to the data. AIDS Behav. 2011 Oct; 15(7):1447-53. View on Pubmed
  26. Saberi P, Neilands TB, Johnson MO. Quality of sleep: associations with antiretroviral nonadherence. AIDS Patient Care STDS. 2011 Sep; 25(9):517-24. View on Pubmed
  27. Bruno CB, Schapiro JM, Saberi P. An Increase in Serum Creatinine after Initiation of Fenofibrate in an HIV-Infected Individual: A Case Report and Review of the Literature. J Int Assoc Physicians AIDS Care (Chic). 2011 Jul-Aug; 10(4):219-22. View on Pubmed
  28. Saberi P, Ranatunga DK, Quesenberry CP, Silverberg MJ. Clinical implications of the nelfinavir-proton pump inhibitor drug interaction in patients with human immunodeficiency virus. Pharmacotherapy. 2011 Mar; 31(3):253-61. View on Pubmed
  29. Ma A, Chen DM, Chau FM, Saberi P. Improving adherence and clinical outcomes through an HIV pharmacist's interventions. AIDS Care. 2010 Oct; 22(10):1189-94. View on Pubmed
  30. Saberi P, Caswell N, Amodio-Groton M, Alpert P. Pharmacy-refill measure of adherence to efavirenz can predict maintenance of HIV viral suppression. AIDS Care. 2008 Jul; 20(6):741-5. View on Pubmed
  31. Saberi P, Caswell NH, Gruta CI, Tokumoto JN, Dong BJ. Immunologic benefits of enfuvirtide in patients enrolled in a drug assistance program. Ann Pharmacother. 2008 May; 42(5):621-6. View on Pubmed
  32. Saberi P, Caswell NH, Gruta CI, Tokumoto JN, Dong BJ. Immunologic benefits of enfuvirtide in patients enrolled in a drug assistance program. Ann Pharmacother. 2008 May; 42(5):621-6. View on Pubmed